The Comgest Growth Europe ex-UK fund added six positions in a busy 2019 as manager Alistair Wittet bought amid market volatility, having offloaded its holding in Wirecard, although he did not rule out buying back in once its accounting investigations are completed.
The fund upped its bet on the ageing population megatrend by buying hearing aid retailer Amplifon, drug development solutions provider Icon and nursing home provider Orpea. As at 31 December, the fund had 30.4% in healthcare. Wittet said the ageing population megatrend was "almost a cliché now", but an important one for investors to take advantage of. Health spending has grown every single year since the 1960s in the US, he explained. The same is true of the UK since 1997. Wittet said both Amplifon and Orpea are high-quality players in structurally growing markets, with the former ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
